Explore Watchlists Pricing

kainos loboratories,inc (4556) Balance sheet

Market cap

¥10.4B

P/E ratio

16x

Kainos manufactures diagnostic pharmaceuticals, laboratory reagents, and medical devices for hospitals and research facilities to improve healthcare quality.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	1,347	1,141	1,202	1,196	953	1,964	2,244	2,677	3,020	3,174	3,396	4,174
Marketable securities, current	-	-	-	-	100	-	-	-	-	-	-	-	-
Inventories	-	220	273	254	255	378	361	307	331	405	441	446	441
Total current assets	-	3,042	2,917	2,814	3,127	2,830	3,806	4,058	4,690	5,219	5,694	5,821	6,508
Property, plant and equipment, net	-	2,825	2,767	2,749	2,621	2,572	2,539	2,532	2,535	2,547	2,506	2,515	2,550
Marketable securities, non-current	-	184	163	208	190	167	132	157	154	168	219	262	356
Total non-current assets	-	3,175	2,992	2,990	3,018	3,028	2,939	2,904	2,881	2,897	2,897	2,965	3,059
Total assets	-	6,216	5,909	5,803	6,145	5,859	6,745	6,962	7,572	8,116	8,591	8,785	9,567
Short-term debt	-	660	560	400	400	350	300	300	280	240	240	-	100
Long-term debt, current	-	300	100	200	300	100	200	300	100	200	300	100	150
Total current liabilities	-	2,538	1,975	1,707	1,925	1,660	1,848	1,894	1,781	1,916	1,980	1,457	1,963
Total non-current liabilities	-	394	583	453	365	563	515	409	590	530	344	553	365
Total liabilities	-	2,933	2,559	2,160	2,290	2,223	2,363	2,303	2,371	2,446	2,325	2,010	2,329
Retained earnings	-	1,578	1,804	2,046	2,268	2,598	2,868	3,219	3,666	4,123	4,650	5,148	5,442
Stockholders' equity	3,073	3,284	3,350	3,643	3,855	3,635	4,381	4,660	5,200	5,670	6,266	6,775	7,238